Suven Life Sciences Ltd. - Research Center

---

Results

• Quarterly
• Half yearly
• Annual

Statement

• Balance sheet
• P&L
• Cash flow

More

• Dividend
• Bonus
• Share holding
• Capital structures
• Ratio

Mar ' 24	Mar ' 23	Mar ' 22	Mar ' 21	Mar ' 20

Sales

11.69

13.54

11.84

13.48

14.41

Operating profit

-30.94

-27.74

-36.64

-30.55

-35.26

Interest

0.16

0.29

0.53

0.82

0.54

Gross profit

-9.97

-19.58

-31.86

-23.61

-21.77

EPS (Rs)

-0.37

-0.92

-2.49

-1.78

-1.08

Other income

21.13

8.45

5.32

7.75

14.04

Stock adjustment

-

-

-

-

-

Raw material

-

-

-

-

-

Power and fuel

-

-

-

-

-

Employee expenses

16.53

15.77

17.46

15.29

14.60

Excise

-

-

-

-

-

Admin and selling expenses

-

-

-

-

-

Research and development expenses

20.39

20.50

-

25.17

25.94

Expenses capitalised

-

-

-

-

-

Other expenses

5.71

5.01

31.02

3.57

9.14

Provisions made

-

-

-

-

-

Depreciation

6.50

6.54

4.39

4.35

4.17

Taxation

-1.00

-

-

-5.32

-12.18

Net profit / loss

-8.01

-20.13

-36.25

-22.63

-13.75

Extra ordinary item

7.46

6.00

-

-

-

Prior year adjustments

-

-

-

-

-

Equity capital

21.81

21.81

14.54

12.73

12.73

Equity dividend rate

-

-

-

-

-

Agg.of non-prom. shares (Lacs)

-

-

-

-

-

Agg.of non promotoholding (%)

-

-

-

-

-

OPM (%)

-264.58

-204.92

-309.37

-226.64

-244.63

GPM (%)

-30.36

-89.07

-185.62

-111.19

-76.51

NPM (%)

-24.40

-91.54

-211.22

-106.59

-48.34